NCT05320718

Brief Summary

Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide effective analgesia after thoracic and cardiac surgery. We hypothesized that the ESPB is non-inferior to PVB in treating pain in minimally invasive direct coronary artery bypass surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

April 15, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

April 23, 2026

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

March 21, 2022

Last Update Submit

April 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • pain at cough after surgery

    Numerical Rating Pain Scale, where 0=No Pain (better outcome) and 10=Intractable Pain (worse outcome)

    postoperatively 0-3 day

  • postoperative rescue analgesic consumption

    morphine equivalents

    postoperatively 0-3 day

Secondary Outcomes (3)

  • pain at rest after surgery

    postoperatively 0-3 day

  • adverse events of regional block

    Intraoperative (during and immediately after block performance)

  • dermatome of block

    immediately after extubation

Other Outcomes (10)

  • pulmonary function

    preoperative and postoperative day 1 and 3

  • postoperative complications: cardiac, pulmonary, cerebral, opioid intake

    3 days postoperatively

  • recovery time

    postoperatively, up to 4 weeks

  • +7 more other outcomes

Study Arms (2)

erector spinae plane block

EXPERIMENTAL

A needle is inserted until the tip contacted the T5 transverse process under ultrasound guidance. After confirming the needle tip position, 20 ml of 0.5% ropivacaine was injected in the plane between the erector spinae muscles and transverse process. A catheter is inserted through the needle and then connected to a Programmed Electronic Postoperative Analgesia Pump with a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery

Drug: Ropivacaine

thoracic paravertebral block

ACTIVE COMPARATOR

A needle is inserted into the paravertebral space. After confirming the needle tip position, 20 ml of 0.5% ropivacaine is injected in the paravertebral space. A catheter is inserted through the needle and then connected to a Programmed Electronic Postoperative Analgesia Pump with a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery.

Drug: Ropivacaine

Interventions

20 ml of 0.5% ropivacaine as bolus and a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery

erector spinae plane blockthoracic paravertebral block

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing elective minimally invasive direct coronary artery bypass grafting

You may not qualify if:

  • Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al)
  • Morbid obesity (body mass index \> 35 kg/m2)
  • Allergy to any of the study drugs
  • Chronic opioid use or history of opioid abuse.
  • Inability to understand pain score

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Anesthesiology,Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Peking University Third Hosptial

Beijing, 100191, China

Location

Related Publications (3)

  • Gurkan Y, Aksu C, Kus A, Yorukoglu UH. Erector spinae plane block and thoracic paravertebral block for breast surgery compared to IV-morphine: A randomized controlled trial. J Clin Anesth. 2020 Feb;59:84-88. doi: 10.1016/j.jclinane.2019.06.036. Epub 2019 Jul 4.

    PMID: 31280100BACKGROUND
  • Saadawi M, Layera S, Aliste J, Bravo D, Leurcharusmee P, Tran Q. Erector spinae plane block: A narrative review with systematic analysis of the evidence pertaining to clinical indications and alternative truncal blocks. J Clin Anesth. 2021 Feb;68:110063. doi: 10.1016/j.jclinane.2020.110063. Epub 2020 Oct 5.

    PMID: 33032124BACKGROUND
  • Huang W, Wang W, Xie W, Chen Z, Liu Y. Erector spinae plane block for postoperative analgesia in breast and thoracic surgery: A systematic review and meta-analysis. J Clin Anesth. 2020 Nov;66:109900. doi: 10.1016/j.jclinane.2020.109900. Epub 2020 Jun 2.

    PMID: 32502778BACKGROUND

MeSH Terms

Interventions

Ropivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Min Li, MD

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Director of the Department of Anesthesiology, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

March 21, 2022

First Posted

April 11, 2022

Study Start

April 15, 2022

Primary Completion

April 30, 2023

Study Completion

December 30, 2023

Last Updated

April 23, 2026

Record last verified: 2025-01

Locations